×
0 0 0 0 0 0 0 0
Stockreport

BRIEF-Novartis Announces Data From Trial To Show Superior Efficacy Of Gilenya Over Copaxone In Patients With Relapsing Remitting Multiple Sclerosis [Reuters]

Novartis (NVS)  More Company Research Source: Reuters
Last novartis earnings: 10/19 04:01 pm Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF BRIEF-Novartis Announces Data From Trial To Show Superior Efficacy Of Gilenya Over Copaxone In Patients With Relapsing Remitting Multiple Sclerosis | Reuters 1 Min Read Oct 10 (Reuters) - Novartis AG: * NOVARTIS ANNOUNCES NEW DATA FROM THE FIRST DIRECT HEAD-TO-HEAD TRIAL TO DEMONSTRATE SUPERIOR EFFICACY OF GILENYA® OVER COPAXONE® IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS * SAYS DATA SHOW THAT GILENYA 0.5MG MET ITS PRIMARY ENDPOINT OF SIGNIFICANTLY REDUCING ANNUALIZED RELAPSE RATE COMPARED TO COPAXONE * SAFETY OF GILENYA OBSERVED IN ASSESS ACROSS BOTH DOSES WAS CONSISTENT WITH KNOWN SAFETY PROFILE OF DRUG Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2018 Reuters. All Rights Reserved. BRIEF-Novartis Announces Data From Trial To Show Superior Efficacy Of Gilenya Over Copaxone In Patients With Relapsing Remitting Multiple Sclerosis Oct 10 (Reuters) - Novartis AG: [Read more]

IMPACT SNAPSHOT EVENT TIME: NVS
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
NVS alerts
from News Quantified
Opt-in for
NVS alerts

from News Quantified
Opt-in for
NVS alerts

from News Quantified